News and Opinions
Worms With a Superpower – Stanford Scientists Unravel Secrets of Regeneration
By Stanford University School of Engineering - SciTech Daily When an injury occurs in many organisms, a whole-body response is triggered, possibly aiding in healing and regeneration; this is seen in mice, axolotls, zebrafish, and planarian worms. In planarians,...
CAR-T cell researchers at Mayo Clinic optimistic about future of treating blood cancers
By Kelley Luckstein - Mayo Clinic ROCHESTER, Minn. — Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers. “Five years ago, the survival rate for people with blood cancers...
Lawsuit alleges businesses sold fraudulent stem cell therapy to 250 Iowans totaling $1M
Noelle Alviz-Gransee - Des Moines Register Iowa Attorney General Brenna Bird sued two businesses and their owners for allegedly selling fraudulent stem cell therapy treatments to more than 250 Iowans. The lawsuit filed against Biologics Health LLC, Summit Partners...
Bioengineered instrument reveals hidden cancer cells
By Taylor Mixides - Drug Target Review Scientists at Stanford University have engineered a biomolecule that can specifically remove mucins from cancer cells. This breakthrough could have a significant impact on future cancer therapies. Cancer cells can elude the...
From Lift Off to Splash Down: An Update on Mayo Clinic Stem Cells in Space
By Lynda De Widt - Mayo Clinic Growing up in Nigeria, Dr. Zubair had high ambitions, including dreams of becoming an astronaut. Though he has not taken flight, his work has – literally. In 2017, several samples of donated stem cells from Dr. Zubair's lab were on...
NASA, Partners Clear Axiom Space’s Third Private Astronaut Crew
By NASA NASA and its international partners approved the crew for Axiom Space’s third private astronaut mission to the International Space Station, launching from the agency’s Kennedy Space Center in Florida no earlier than January 2024. Axiom Space’s chief astronaut...
Ian Wilmut, Scientist Behind Dolly the Cloned Sheep, Is Dead at 79
By Clay Risen and Amanda Holpuch - The New York Times Ian Wilmut, the British scientist who led the project that cloned a mammal for the first time, Dolly the sheep, shocking scientists who had thought that such a procedure was impossible, died on Sunday. He was 79....
CRISPR used to ‘reprogram’ cancer cells into healthy muscle in the lab
by Live Science Scientists have transformed cancer cells into healthy muscle tissue in the lab using CRISPR gene-editing technology — and they hope new cancer treatments can be built on the back of this experiment. In a study published Aug. 28 in the journal PNAS,...
Gene therapy for brain tumor shows promising early results in humans
by Ann Megdell - Michigan Medicine A study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival...
Single Dose of CRISPR Treatment Removes HIV-Like Virus From Monkey Genome
by Technology Networks News A single injection of a novel CRISPR gene-editing treatment safely and efficiently removes SIV – a virus related to the AIDS-causing agent HIV – from the genomes of non-human primates, scientists at the Lewis Katz School of Medicine at...
Obituary: Professor Sir Ian Wilmut
by University of Edinburgh A world-renowned embryologist and specialist in regenerative medicine, Sir Ian led the team that cloned Dolly the Sheep in 1996 – the first mammal to be cloned from an adult cell. Some 27 years on, the breakthrough continues to fuel many of...
Stem Cell Studies Suggest Mechanism by Which Gene Increases Risk of Sporadic Alzheimer’s Disease
by Genetic Engineering & Biotechnology News A research team headed by investigators at Brigham and Women’s Hospital reported on the results of a study in which they used stem cells from Alzheimer’s disease (AD) patients to identify a potential mechanism by which a...
UCSD launches gene therapy initiative with help of $5 million gift from Stack foundation
By Paul Sisson - The San Diego Tribune A newly announced $5 million donation to UC San Diego that will support a new gene therapy initiative illustrates the value of making good on big promises. The contribution is the latest from philanthropists Nancy and Jeff Stack...
New study shows promising evidence for sickle cell gene therapy
By Grace Niewijk - University of Chicago Medicine New research published in the New England Journal of Medicine indicates that stem cell gene therapy may offer a promising, curative treatment for the painful, inherited blood disorder sickle cell disease (SCD). The...
https://cdn.drugdiscoverynews.com/assets/articleNo/15745/aImg/40592/60950-ddn-article-image-diabetes-elk-m.webp
by Sarah Anderson, PhD - Exploring Drug Discovery and Development Like a differentiated stem cell, Lonnie Shea’s strong foundation in fundamental cellular biology underwent just the right prompts to evolve into a proliferative biomedical research career. During...
Cell therapy that repairs cornea damage with patient’s own stem cells achieves positive phase I trial results
by Massachusetts Eye and Ear Infirmary A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation...
A Review of Human Disease Models in Drug Development
By Florina Gobel - Center for Contemporary Sciences In the article Human disease models in drug development published in Nature, the authors delve into the critical role of human disease models in drug development, emphasizing the importance of bridging the gap...
Modified neural stem cells for spinal cord injury
By Drug Target Review Using genetically modified human neural stem cells (hNSCs), researchers demonstrated that targeted manipulation of a specific gene expression within hNSCs can facilitate the restoration of damaged neural circuits and recovery of locomotor...
Wiping stem cells ‘clean’ could make them easier to produce
By Jason Arunn Murugesu - NewScientist A technique for reprogramming adult cells that removes any trace of their origins could help produce stem cells at larger scales A new way to turn adult human cells into ultra-flexible stem cells could make it easier to produce...
Building muscle in the lab
by Fabio Bergamin - ETH Zurich Professor Ori Bar-Nur and his team grow muscle cells in the laboratory. In this case, they are mouse cells, but the researchers are also interested in human and cow cells. Promising applications resonate with both: human muscle tissue...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.


















